Remdesivir is associated with reduced readmission after COVID-19 hospitalization Mozaffari et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Remdesivir reduces mortality in hospitalized COVID-19 patients across variant eras Mozaffari et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Remdesivir reduces mortality in immunocompromised patients hospitalized for COVID-19 Mozaffari et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Predictors of Hepatitis B Treatment Response in People with HIV-1/HBV coinfection Avihingsanon et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Week 52 Subgroup Efficacy of Lenacapavir in Heavily Treatment-Experienced PLWH Ogbuagu et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

BICSTaR 24-month results

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Treatment of PLWH with Biktarvy^® in a real world setting in Belgium

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Framingham on HIV / AIDS issue 1 – 2023

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Framingham on HIV / AIDS issue 3 – 2022

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

A retrospective, multicenter study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy^®) for the treatment of HIV in a real-world setting in Belgium Nasreddine et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy^®) for the treatment of People Living with HIV: 24-Month Analyses by Age, Race, Sex, Adherence and Late Diagnosis in a Multi-Country Cohort Study Trottier et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Outcomes After Switching From 144 Weeks of Blinded DTG/ABC/3TC or DTG + FTC/TAF to 96 Weeks of Open-label Biktarvy^® Orkin et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...